LONG-TERM RESULTS IN THE TREATMENT OF EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT ALPHA-2C INTERFERON

被引：0
|
作者：
GISSLINGER, H
LINKESCH, W
CHOTT, A
SINZINGER, H
LUDWIG, H
机构：
[1] VIENNA UNIV,DEPT MED 2,A-1010 VIENNA,AUSTRIA
[2] VIENNA UNIV,INST PATHOL,A-1010 VIENNA,AUSTRIA
来源：
BLUT | 1986年 / 53卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [21] Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin
    Barnes, E
    Webster, G
    Jacobs, R
    Dusheiko, G
    JOURNAL OF HEPATOLOGY, 1999, 31 : 244 - 249
  • [22] Long-term efficacy of interferon alpha treatment in chronic hepatitis C
    Berg, T
    Kaul, T
    Heuft, HG
    Naumann, U
    Lobeck, H
    Wiedenmann, B
    Hopf, U
    JOURNAL OF HEPATOLOGY, 1998, 29 (03) : 511 - 512
  • [23] KAPOSIS SARCOMA IN AIDS PATIENTS - LONG-TERM TREATMENT WITH RECOMBINANT INTERFERON ALPHA-2A AND CHEMOTHERAPY
    FLEPP, M
    TAUBER, MG
    LUTHY, R
    SIEGENTHALER, W
    KLINISCHE WOCHENSCHRIFT, 1988, 66 (10): : 437 - 442
  • [24] IMMUNOMODULATION BY LONG-TERM TREATMENT OF CANCER-PATIENTS WITH RECOMBINANT INTERFERON-ALPHA-2 (IFN)
    TEICHMANN, JV
    SIEBER, G
    LUDWIG, WD
    RUEHL, H
    JOURNAL OF INTERFERON RESEARCH, 1987, 7 (06): : 810 - 810
  • [25] THYROID AUTOIMMUNITY AND HYPOTHYROIDISM DURING LONG-TERM TREATMENT WITH RECOMBINANT INTERFERON-ALPHA
    GISSLINGER, H
    GILLY, B
    WOLOSZCZUK, W
    MAYR, WR
    HAVELEC, L
    LINKESCH, W
    WEISSEL, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 90 (03): : 363 - 367
  • [26] INTERFERON (IFN) THERAPY (RECOMBINANT ALPHA-2C IFN OR RECOMBINANT GAMMA-IFN) IN METASTASIZED HYPERNEPHROMAS
    KUZMITS, R
    SCHEITHAUER, W
    LUDWIG, H
    FLENER, R
    ACTA MEDICA AUSTRIACA, 1985, 12 : 43 - 43
  • [27] Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia
    Lauta, VM
    DeSangro, MA
    MEDICAL ONCOLOGY, 1995, 12 (04): : 223 - 230
  • [28] Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors - An antiangiogenic effect?
    Dirix, LY
    Vermeulen, PB
    Fierens, H
    DeSchepper, B
    Corthouts, B
    VanOosterom, AT
    ANTI-CANCER DRUGS, 1996, 7 (02) : 175 - 181
  • [29] TREATMENT WITH RECOMBINANT INTERFERON-ALPHA-2C - MULTIPLE-MYELOMA AND THROMBOCYTHEMIA IN MYELOPROLIFERATIVE DISEASES
    LUDWIG, H
    CORTELEZZI, A
    VANCAMP, BGK
    POLLI, E
    SCHEITHAUER, W
    KUZMITS, R
    LINKESCH, W
    GISSLINGER, H
    SINZINGER, H
    FRITZ, E
    FLENER, R
    ONCOLOGY, 1985, 42 : 19 - 25
  • [30] EFFECT OF RECOMBINANT INTERFERON-ALPHA-2C ON RETICULOENDOTHELIAL FUNCTION IN PATIENTS WITH THROMBOCYTOSIS
    SCHEITHAUER, W
    GISSLINGER, H
    TEMSCH, EM
    LINKESCH, M
    LINKESCH, W
    LUDWIG, H
    JOURNAL OF INTERFERON RESEARCH, 1990, 10 (02): : 237 - 242
12345